Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_assertion type Assertion NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_head.
- NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_provenance.
- NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_assertion evidence source_evidence_literature NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_provenance.
- NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_assertion SIO_000772 20959405 NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_provenance.
- NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_assertion wasDerivedFrom gad-20130706 NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_provenance.
- NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_assertion wasGeneratedBy ECO_0000203 NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_provenance.